Information  X 
Enter a valid email address

Aquis Exchange PLC (AQX)

  Print   

Thursday 23 September, 2021

Aquis Exchange PLC

Exercise of Share Options, Director Dealing & TVR

RNS Number : 8249M
Aquis Exchange PLC
23 September 2021
 

23 September 2021

Aquis Exchange PLC

("Aquis" or the "Company")

 Exercise of Share Options, Director Dealing and Total Voting Rights

Aquis Exchange PLC (AIM: AQX), the exchange services group, announces that on 22 September 2021 it received notification that certain employees have exercised options under the Company's EMI Option Scheme over 9,294 ordinary shares of 10p each in the Company ("Ordinary Shares") at an exercise price of £2.69 per share.

In addition, Jonathan Clelland, CFO and COO of the Company, on 23 September 2021 sold 100,000 Ordinary Shares at a price of £7.20 following the exercise of options under the Company's EMI Option Scheme in June of this year. Following this, Jonathan Clelland now holds 547,401 Ordinary Shares in the Company, representing 2.0% of the Company's issued share capital.

Application has been made for 9,294 new Ordinary Shares to be admitted to trading on AIM, which is expected to take place on 1 October 2021. The new Ordinary Shares will rank pari pasu with the existing Ordinary Shares in issue.

Total Voting Rights

In accordance with the provisions of the Disclosure Guidance and Transparency Rules of the FCA, the Company confirms that, following this issue, its issued share capital will comprise 27,502,257 Ordinary Shares. All Ordinary Shares shall have equal voting rights and none of the Ordinary Shares are held in treasury. Accordingly, the figure of 27,502,257 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

Enquiries:

Aquis Exchange PLC

Tel: +44 (0) 7768 078 110

Belinda Keheyan, Head of Marketing




Liberum Capital Limited (Nominated Adviser and Joint Broker)

Tel: +44 (0) 20 3100 2000

Chris Clarke


Clayton Bush


Edward Thomas


Kane Collings




Canaccord Genuity Limited (Joint Broker)

Tel: +44 (0) 20 7523 8000

Bobbie Hilliam (Corporate Broking)






Alma PR (Financial PR Adviser)

Tel: +44 (0)20 3405 0209

Susie Hudson

[email protected]

Kieran Breheny


Faye Calow


 

 

Notes to Editors

About Aquis Exchange

Aquis Exchange PLC is an exchange services group, which operates pan-European cash equities trading businesses (Aquis Exchange), growth and regulated primary markets (Aquis Stock Exchange/AQSE) and develops/licenses exchange software to third parties (Aquis Technologies).

Aquis Exchange is authorised and regulated by the UK Financial Conduct Authority and France's Autorité des Marchés Financiers to operate Multilateral Trading Facility businesses in the UK and in EU27 respectively. Aquis operates a lit order book and does not allow aggressive non-client proprietary trading, which has resulted in lower toxicity and signalling risk on Aquis than other trading venues in Europe. According to independent studies, trades on Aquis are less likely to lead to price movement than on other lit markets. Aquis uses a subscription pricing model which works by charging users according to the message traffic they generate, rather than a percentage of the value of each stock that they trade.

Aquis Stock Exchange (AQSE) is a stock market providing primary and secondary markets for equity and debt products. It is authorised as a Recognised Investment Exchange, which allows it to operate a regulated listings venue. AQSE, which used to be known as NEX Exchange Ltd., was acquired by Aquis in March 2020 from CME Inc. The AQSE Growth Market is divided into two segments 'Access' and 'Apex', with different levels of admission criteria. The Access market focuses on earlier stage growth companies, while Apex is the intended market for larger, more established businesses.

Aquis Technologies is the software and technology division of Aquis Exchange PLC. It creates and licenses cutting-edge, cost-effective matching engine and trade surveillance technology for banks, brokers, investment firms and exchanges.

Aquis Exchange PLC (AQX.L) is listed on the Alternative Investment Market of the LSE (AIM) market. For more information, please go to  www.aquis.eu

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Jonathan Clelland

2

Reason for the notification

 

a)

Position/status

 

Chief Financial Officer and Chief Operating Officer

b)

Initial notification/ Amendment

 

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Aquis Exchange plc

b)

LEI

 

213800IXJSF5E1SIW150

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

Identification code

 

 

Ordinary shares of 10 pence each

 

ISIN: GB00BD5JNK30

b)

Nature of the transaction

 

Sale of ordinary shares

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

 

£7.20

 

 

100,000

 

d)

Aggregated information

- Aggregated volume

- Price

 

 

 

n/a - as above

e)

Date of the transaction

 

23/09/2021

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRFZGZLVFRGMZM

a d v e r t i s e m e n t